Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated ...

Aminoglycoside antibiotics are a central component of the treatment of pulmonary exacerbations of cystic fibrosis (CF) and slow the decline in lung function which ultimately causes the death of most ...

At 7 years old, Morgan Barrett was diagnosed with cystic fibrosis. Prior to her diagnosis, she struggled to gain weight ...

North Carolina man created a foundation to help other patients navigate expenses of an unexpectedly longer life ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated ...

Study maps proteostasis changes in cystic fibrosis variants, revealing NBD1 structural instabilities that limit drug response ...

Boehringer Ingelheim (BI) and the UK Cystic Fibrosis Gene Therapy Consortium announced a global collaboration to develop a first-in-class, long-term therapy for patients with cystic fibrosis (CF ...

SELINSGROVE — Growing up, Bethany Umholtz-Boyer didn’t really have any long-term life plans. Her lack of planning for the ...

Cystic fibrosis (CF) is a life-shortening genetic disease affecting approximately 70 000 individuals worldwide. Until recently, drug development efforts have emphasised therapies treating downstream ...

After intravenous administration, serum half-life is 4 to 6 hours in adults. The drug is eliminated by the kidney; 80% to 90% of it appears in the urine within 24 hours.